GLP-1 Gold Rush — Who’s Really Winning in the New Obesity Market?  

In this episode of The Syneos Health Podcast: Conversations on Commercialization, Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 therapies. 

You’ll hear: 

- What emerging launch strategies look like in a crowded pipeline and how success is being redefined 
- How GLP-1s are accelerating a shift in stakeholder dynamics, including telehealth, large employers and direct-to-patient platforms
- Why traditional DTC advertising is evolving and how informed patients are influencing brand messaging 

Like what you’re hearing? Find the full Conversations on Commercialization podcast stream here. Also available anywhere you listen to podcasts.

Be sure to rate and review us!

We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].